| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | TRERF1 NCOR2 MED6 RCOR1 ZMYND11 BRD8 PPRC1 BCORL1 NUCKS1 KDM2B GON4L SMARCC2 SMARCE1 ELK1 SPEN MED12 | 7.57e-09 | 562 | 94 | 16 | GO:0003712 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TRERF1 NCOR2 MED6 RCOR1 ZMYND11 BRD8 FXR1 ANK3 PPRC1 G3BP2 BCORL1 NUCKS1 KDM2B GON4L SMARCC2 SMARCE1 ELK1 ZZEF1 SPEN MED12 AKAP12 | 7.56e-08 | 1160 | 94 | 21 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | TRERF1 NCOR2 MED6 RCOR1 ZMYND11 BRD8 FXR1 ANK3 PPRC1 G3BP2 BCORL1 NUCKS1 KDM2B GON4L SMARCC2 SMARCE1 ELK1 LTBP1 ZZEF1 SPEN MED12 AKAP12 | 2.36e-07 | 1356 | 94 | 22 | GO:0060090 |
| GeneOntologyMolecularFunction | nuclear receptor coactivator activity | 1.00e-05 | 61 | 94 | 5 | GO:0030374 | |
| GeneOntologyMolecularFunction | transcription coactivator activity | 1.30e-05 | 303 | 94 | 9 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription factor binding | TRERF1 ATF7 NCOR2 MED6 BRD8 PPRC1 ZNF618 KDM5C NUCKS1 SMARCE1 ELK1 SPEN MED12 | 5.07e-05 | 753 | 94 | 13 | GO:0008134 |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.05e-04 | 229 | 94 | 7 | GO:0003714 | |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | 7.87e-04 | 417 | 94 | 8 | GO:0061629 | |
| GeneOntologyBiologicalProcess | mRNA transport | 1.90e-08 | 145 | 93 | 9 | GO:0051028 | |
| GeneOntologyBiologicalProcess | RNA transport | 9.68e-08 | 175 | 93 | 9 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 9.68e-08 | 175 | 93 | 9 | GO:0050657 | |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.12e-07 | 178 | 93 | 9 | GO:0051236 | |
| GeneOntologyBiologicalProcess | RNA localization | 5.99e-07 | 217 | 93 | 9 | GO:0006403 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 1.88e-06 | 249 | 93 | 9 | GO:0015931 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | RTF1 RLF MED6 RCOR1 ZMYND11 BRD8 KDM5C BCORL1 RSF1 MKI67 NUCKS1 NASP KDM2B SMARCC2 SMARCE1 ZZEF1 NSD3 | 2.06e-06 | 999 | 93 | 17 | GO:0071824 |
| GeneOntologyBiologicalProcess | chromatin organization | RTF1 RLF RCOR1 ZMYND11 BRD8 KDM5C BCORL1 RSF1 MKI67 NUCKS1 NASP KDM2B SMARCC2 SMARCE1 ZZEF1 NSD3 | 2.32e-06 | 896 | 93 | 16 | GO:0006325 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | RTF1 TRERF1 ATF7 NCOR2 RCOR1 ZMYND11 ZFP3 PTPRK KDM5C BCORL1 RSF1 KDM2B GON4L SMARCC2 SMARCE1 CCAR2 SARNP SPEN NSD3 | 1.27e-05 | 1399 | 93 | 19 | GO:0045892 |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | RTF1 TRERF1 ATF7 NCOR2 RCOR1 ZMYND11 ZFP3 PTPRK KDM5C BCORL1 RSF1 KDM2B GON4L SMARCC2 SMARCE1 CCAR2 SARNP SPEN NSD3 | 1.47e-05 | 1413 | 93 | 19 | GO:1902679 |
| GeneOntologyBiologicalProcess | mRNA export from nucleus | 2.11e-05 | 74 | 93 | 5 | GO:0006406 | |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 7.39e-05 | 96 | 93 | 5 | GO:0006405 | |
| GeneOntologyBiologicalProcess | poly(A)+ mRNA export from nucleus | 1.90e-04 | 25 | 93 | 3 | GO:0016973 | |
| GeneOntologyBiologicalProcess | nuclear export | 1.92e-04 | 185 | 93 | 6 | GO:0051168 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | THOC1 RTF1 TRERF1 WDR3 ATF7 SRRM1 NCOR2 RANBP2 MED6 RCOR1 ZC3H11A BRD8 CHMP4A RSF1 KDM2B GON4L SMARCC2 SMARCE1 SMG5 UPF3A INTS3 SARNP MED12 | 3.72e-08 | 1377 | 95 | 23 | GO:0140513 |
| GeneOntologyCellularComponent | transcription export complex | 1.94e-05 | 12 | 95 | 3 | GO:0000346 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 7.69e-05 | 96 | 95 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | chromosomal region | 1.28e-04 | 421 | 95 | 9 | GO:0098687 | |
| GeneOntologyCellularComponent | costamere | 1.32e-04 | 22 | 95 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 2.66e-04 | 276 | 95 | 7 | GO:0000775 | |
| GeneOntologyCellularComponent | ATPase complex | 3.08e-04 | 129 | 95 | 5 | GO:1904949 | |
| GeneOntologyCellularComponent | nuclear matrix | 4.48e-04 | 140 | 95 | 5 | GO:0016363 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 6.12e-04 | 85 | 95 | 4 | GO:0000118 | |
| GeneOntologyCellularComponent | bBAF complex | 8.98e-04 | 10 | 95 | 2 | GO:0140092 | |
| GeneOntologyCellularComponent | chromatin | PPP4R3B ATF7 NCOR2 BRD8 ZNF618 KDM5C RSF1 NUCKS1 NASP GON4L ANKRD17 SMARCC2 SMARCE1 CCAR2 ELK1 NSD3 | 9.82e-04 | 1480 | 95 | 16 | GO:0000785 |
| GeneOntologyCellularComponent | cell body | NEFM DSCAM MAP1B PTPRK NCAM1 CACNA1G ELK1 LTBP1 SLC24A1 SLC1A2 ALK AKAP12 | 1.01e-03 | 929 | 95 | 12 | GO:0044297 |
| GeneOntologyCellularComponent | nuclear periphery | 1.11e-03 | 171 | 95 | 5 | GO:0034399 | |
| GeneOntologyCellularComponent | somatodendritic compartment | NEFM FXR1 ANK3 DSCAM MAP1B PTPRK NCAM1 CACNA1G ELK1 LTBP1 SRGAP2 SLC24A1 SLC1A2 AKAP12 | 1.27e-03 | 1228 | 95 | 14 | GO:0036477 |
| GeneOntologyCellularComponent | kinetochore | 1.42e-03 | 181 | 95 | 5 | GO:0000776 | |
| GeneOntologyCellularComponent | npBAF complex | 1.79e-03 | 14 | 95 | 2 | GO:0071564 | |
| GeneOntologyCellularComponent | brahma complex | 1.79e-03 | 14 | 95 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | condensed chromosome, centromeric region | 1.89e-03 | 193 | 95 | 5 | GO:0000779 | |
| GeneOntologyCellularComponent | RSC-type complex | 2.06e-03 | 15 | 95 | 2 | GO:0016586 | |
| GeneOntologyCellularComponent | nBAF complex | 2.35e-03 | 16 | 95 | 2 | GO:0071565 | |
| GeneOntologyCellularComponent | condensed chromosome | 2.78e-03 | 307 | 95 | 6 | GO:0000793 | |
| Domain | MYB_LIKE | 1.15e-06 | 38 | 92 | 5 | PS50090 | |
| Domain | SANT | 4.62e-06 | 50 | 92 | 5 | SM00717 | |
| Domain | SANT/Myb | 5.63e-06 | 52 | 92 | 5 | IPR001005 | |
| Domain | SANT_dom | 7.59e-06 | 26 | 92 | 4 | IPR017884 | |
| Domain | SANT | 1.03e-05 | 28 | 92 | 4 | PS51293 | |
| Domain | Myb_DNA-binding | 2.57e-05 | 35 | 92 | 4 | PF00249 | |
| Domain | Znf_PHD-finger | 4.39e-05 | 79 | 92 | 5 | IPR019787 | |
| Domain | PHD | 7.78e-05 | 89 | 92 | 5 | SM00249 | |
| Domain | Znf_PHD | 8.65e-05 | 91 | 92 | 5 | IPR001965 | |
| Domain | ZF_PHD_2 | 1.06e-04 | 95 | 92 | 5 | PS50016 | |
| Domain | ZF_PHD_1 | 1.12e-04 | 96 | 92 | 5 | PS01359 | |
| Domain | Zinc_finger_PHD-type_CS | 2.97e-04 | 65 | 92 | 4 | IPR019786 | |
| Domain | PHD | 5.13e-04 | 75 | 92 | 4 | PF00628 | |
| Domain | Znf_FYVE_PHD | 8.01e-04 | 147 | 92 | 5 | IPR011011 | |
| Domain | fn3 | 1.24e-03 | 162 | 92 | 5 | PF00041 | |
| Domain | FERM-adjacent | 1.81e-03 | 13 | 92 | 2 | IPR014847 | |
| Domain | ELM2 | 1.81e-03 | 13 | 92 | 2 | PF01448 | |
| Domain | ELM2 | 1.81e-03 | 13 | 92 | 2 | PS51156 | |
| Domain | ELM2_dom | 1.81e-03 | 13 | 92 | 2 | IPR000949 | |
| Domain | FA | 1.81e-03 | 13 | 92 | 2 | SM01195 | |
| Domain | ELM2 | 1.81e-03 | 13 | 92 | 2 | SM01189 | |
| Domain | FA | 1.81e-03 | 13 | 92 | 2 | PF08736 | |
| Domain | FN3 | 2.22e-03 | 185 | 92 | 5 | SM00060 | |
| Domain | Ig_I-set | 2.49e-03 | 190 | 92 | 5 | IPR013098 | |
| Domain | I-set | 2.49e-03 | 190 | 92 | 5 | PF07679 | |
| Domain | MAM_1 | 2.75e-03 | 16 | 92 | 2 | PS00740 | |
| Domain | FN3 | 3.04e-03 | 199 | 92 | 5 | PS50853 | |
| Domain | MAM | 3.49e-03 | 18 | 92 | 2 | PF00629 | |
| Domain | MAM_dom | 3.49e-03 | 18 | 92 | 2 | IPR000998 | |
| Domain | MAM_2 | 3.49e-03 | 18 | 92 | 2 | PS50060 | |
| Domain | FN3_dom | 3.74e-03 | 209 | 92 | 5 | IPR003961 | |
| Domain | PWWP | 4.30e-03 | 20 | 92 | 2 | SM00293 | |
| Domain | Ez/rad/moesin-like | 4.74e-03 | 21 | 92 | 2 | IPR000798 | |
| Domain | PWWP | 5.68e-03 | 23 | 92 | 2 | PF00855 | |
| Domain | PWWP_dom | 5.68e-03 | 23 | 92 | 2 | IPR000313 | |
| Domain | PWWP | 6.17e-03 | 24 | 92 | 2 | PS50812 | |
| Domain | JmjC | 6.17e-03 | 24 | 92 | 2 | PF02373 | |
| Domain | FERM_CS | 6.17e-03 | 24 | 92 | 2 | IPR019747 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 2.27e-05 | 175 | 69 | 7 | MM14941 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 5.23e-05 | 272 | 69 | 8 | M29619 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 5.55e-05 | 84 | 69 | 5 | M725 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 6.21e-05 | 86 | 69 | 5 | MM15413 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 2.37e-04 | 62 | 69 | 4 | MM15426 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 3.19e-04 | 67 | 69 | 4 | M27694 | |
| Pubmed | THOC1 RTF1 WDR3 PPP4R3B BROX ATF7 SRRM1 NCOR2 RANBP2 MED6 RCOR1 ZMYND11 ZC3H11A BRD8 KDM5C AHNAK RSF1 MKI67 NUCKS1 SMARCC2 SMARCE1 CCAR2 SARNP MED12 NSD3 | 3.26e-17 | 1014 | 96 | 25 | 32416067 | |
| Pubmed | RLF SRRM1 MED6 RCOR1 SLK BRD8 MAP7D3 MAP1B AHNAK BCORL1 RSF1 NASP SPART GON4L RAI14 LTBP1 SPEN SKA1 NOP2 MED12 NSD3 | 6.66e-17 | 645 | 96 | 21 | 25281560 | |
| Pubmed | TRERF1 RLF PPP4R3B ATF7 NCOR2 RANBP2 MED6 RCOR1 TNRC18 ZC3H11A LMAN1 G3BP2 BCORL1 MKI67 NUCKS1 SMARCC2 SMARCE1 CCAR2 SARNP SPEN NOP2 MED12 CCNB1 | 2.56e-14 | 1103 | 96 | 23 | 34189442 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | THOC1 WDR3 SRRM1 NCOR2 RANBP2 ZC3H11A BRD8 MAP7D3 MAP1B AHNAK BCORL1 RSF1 MKI67 SMARCC2 SMARCE1 RP9 SARNP SPEN NOP2 ALK NSD3 | 1.44e-13 | 954 | 96 | 21 | 36373674 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | THOC1 RANBP2 SLK FXR1 MAP7D3 MAP1B EPB41L4B AHNAK G3BP2 MKI67 SPART ANKRD17 SRGAP2 SMG5 SPEN NOP2 AKAP12 CCNB1 | 1.32e-12 | 724 | 96 | 18 | 36232890 |
| Pubmed | TRERF1 NEFM NCOR2 RANBP2 RCOR1 SLK FXR1 ANK3 DSCAM ZNF618 G3BP2 HECTD4 ANKRD17 SMARCC2 NCAM1 CCAR2 SRGAP2 NOP2 SLC1A2 AKAP12 | 1.72e-12 | 963 | 96 | 20 | 28671696 | |
| Pubmed | NEFM SLK ZC3H11A BRD8 ANK3 MAP7D3 MAP1B AHNAK NASP KDM2B SMARCE1 RAI14 SPEN MED12 WIPI2 NSD3 | 2.48e-12 | 549 | 96 | 16 | 38280479 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | THOC1 TRERF1 SRRM1 NCOR2 RANBP2 ZC3H11A BRD8 KDM5C MKI67 NUCKS1 NASP KDM2B ANKRD17 SMARCC2 CCAR2 INTS3 SPEN NOP2 | 3.99e-12 | 774 | 96 | 18 | 15302935 |
| Pubmed | Interaction network of human early embryonic transcription factors. | TRERF1 RLF NCOR2 RANBP2 RCOR1 TNRC18 BCORL1 MKI67 KDM2B SMARCC2 SMARCE1 SPEN MED12 | 1.72e-11 | 351 | 96 | 13 | 38297188 |
| Pubmed | NEFM WDR3 SRRM1 RANBP2 ZC3H11A FXR1 MAP1B AHNAK RSF1 MKI67 ANKRD17 SMARCC2 CCAR2 SPEN NOP2 MED12 | 3.28e-11 | 653 | 96 | 16 | 22586326 | |
| Pubmed | TRERF1 RLF NEFM NCOR2 RANBP2 RCOR1 LMAN1 AHNAK BCORL1 KDM2B ANKRD17 RAI14 MED12 | 1.49e-10 | 418 | 96 | 13 | 34709266 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | NEFM ATF7 NCOR2 RANBP2 ZC3H11A BRD8 FXR1 MAP7D3 MAP1B KDM5C ANKRD17 SMARCC2 SMARCE1 CCAR2 SMG5 INTS3 SPEN | 1.97e-10 | 857 | 96 | 17 | 25609649 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | THOC1 WDR3 ATF7 SRRM1 NCOR2 RANBP2 MED6 RCOR1 ZC3H11A BRD8 MAP7D3 AHNAK BCORL1 MKI67 KDM2B SMARCE1 INTS3 SPEN NOP2 NSD3 | 3.28e-10 | 1294 | 96 | 20 | 30804502 |
| Pubmed | ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair. | 3.82e-10 | 150 | 96 | 9 | 28242625 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RANBP2 SLK ZC3H11A MAP7D3 MAP1B AHNAK RSF1 MKI67 NUCKS1 NASP SPART ANKRD17 SMARCE1 RAI14 SRGAP2 NOP2 AKAP12 | 7.27e-10 | 934 | 96 | 17 | 33916271 |
| Pubmed | SRRM1 NCOR2 ZC3H11A MAP1B AHNAK MKI67 NASP SPART SMARCC2 SMARCE1 CCAR2 SARNP | 1.16e-09 | 399 | 96 | 12 | 35987950 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | NEFM SRRM1 RANBP2 SLK FXR1 ANK3 MAP1B AHNAK G3BP2 NUCKS1 NASP SPART ANKRD17 CCAR2 RAI14 SRGAP2 SARNP AKAP12 | 2.31e-09 | 1149 | 96 | 18 | 35446349 |
| Pubmed | WDR3 SRRM1 ZC3H11A ANK3 MAP7D3 DSCAM EPB41L4B AHNAK MKI67 NCAM1 CCAR2 RAI14 SPEN NOP2 AKAP12 | 3.69e-09 | 777 | 96 | 15 | 35844135 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | SRRM1 NCOR2 RANBP2 SLK ZC3H11A FXR1 LMAN1 MAP1B AHNAK G3BP2 NUCKS1 NASP SPART ANKRD17 SMARCE1 RAI14 INTS3 NOP2 AKAP12 | 5.50e-09 | 1367 | 96 | 19 | 32687490 |
| Pubmed | RANBP2 RCOR1 ZC3H11A FXR1 AHNAK RSF1 SMARCC2 CCAR2 INTS3 SPEN HYDIN CCNB1 | 7.06e-09 | 469 | 96 | 12 | 27634302 | |
| Pubmed | TRERF1 RLF NCOR2 RCOR1 SLK BRD8 G3BP2 BCORL1 MKI67 KDM2B GON4L ANKRD17 SMARCC2 SMARCE1 CCAR2 RAI14 SMG5 SPEN NOP2 | 1.12e-08 | 1429 | 96 | 19 | 35140242 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | RLF SRRM1 ZMYND11 BCORL1 RSF1 MKI67 NASP KDM2B SMARCC2 SMARCE1 SPEN NOP2 NSD3 | 1.34e-08 | 608 | 96 | 13 | 36089195 |
| Pubmed | PPP4R3B SRRM1 RANBP2 ZC3H11A BRD8 KDM5C RSF1 MKI67 NUCKS1 NASP SPEN NOP2 | 1.53e-08 | 503 | 96 | 12 | 16964243 | |
| Pubmed | PPP4R3B TEX2 KDM5C HECTD4 KDM2B SPART ANKRD17 RAI14 CACNA1G SMG5 ZZEF1 GRAMD4 | 2.66e-08 | 529 | 96 | 12 | 14621295 | |
| Pubmed | 2.91e-08 | 246 | 96 | 9 | 15345747 | ||
| Pubmed | TRERF1 PPP4R3B SRRM1 NCOR2 RANBP2 RCOR1 TNRC18 FXR1 G3BP2 MKI67 ANKRD17 RP9 NOP2 | 3.22e-08 | 655 | 96 | 13 | 35819319 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | WDR3 PPP4R3B RANBP2 FXR1 G3BP2 HECTD4 MKI67 ANKRD17 SMARCC2 SARNP NOP2 | 3.94e-08 | 440 | 96 | 11 | 34244565 |
| Pubmed | 6.05e-08 | 268 | 96 | 9 | 33640491 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 7.83e-08 | 130 | 96 | 7 | 35545047 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | WDR3 SRRM1 RANBP2 RCOR1 SMARCC2 SMARCE1 CCAR2 INTS3 NSD3 CCNB1 | 8.24e-08 | 370 | 96 | 10 | 22922362 |
| Pubmed | WDR3 SRRM1 RANBP2 ZC3H11A FXR1 G3BP2 MKI67 ANKRD17 SMARCC2 SMARCE1 RAI14 SARNP NOP2 NSD3 | 8.76e-08 | 847 | 96 | 14 | 35850772 | |
| Pubmed | THOC1 SRRM1 ZC3H11A FXR1 MYLK ANK3 NASP SMARCC2 SMARCE1 SARNP | 1.82e-07 | 403 | 96 | 10 | 35253629 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | RLF WDR3 PPP4R3B NCOR2 RANBP2 ZMYND11 LMAN1 PTPRK AHNAK RSF1 MKI67 SMARCC2 NCAM1 INTS3 NOP2 MED12 | 1.87e-07 | 1203 | 96 | 16 | 29180619 |
| Pubmed | THOC1 SRRM1 FXR1 ANK3 MKI67 SMARCC2 SMARCE1 RAI14 LTBP1 SMG5 NOP2 CCNB1 | 1.88e-07 | 634 | 96 | 12 | 34591612 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | THOC1 NEFM SRRM1 RANBP2 MAP1B ZNF618 HECTD4 NUCKS1 SMARCC2 SMARCE1 UPF3A SARNP SPEN MED12 NSD3 | 2.79e-07 | 1082 | 96 | 15 | 38697112 |
| Pubmed | THOC1 SRRM1 NCOR2 RANBP2 MED6 RCOR1 TNRC18 FXR1 G3BP2 MKI67 KDM2B ANKRD17 SMARCC2 RAI14 UPF3A MED12 | 3.02e-07 | 1247 | 96 | 16 | 27684187 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 5.86e-07 | 256 | 96 | 8 | 33397691 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | RLF PRUNE2 ATF7 NCOR2 TNRC18 ZC3H11A ANK3 MAP1B EPB41L4B HECTD4 ANKRD17 RAI14 SRGAP2 INTS3 ARMC2 PCDH1 FRMD3 | 6.29e-07 | 1489 | 96 | 17 | 28611215 |
| Pubmed | 7.92e-07 | 114 | 96 | 6 | 31553912 | ||
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 8.29e-07 | 184 | 96 | 7 | 32908313 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RLF WDR3 NCOR2 RANBP2 ZC3H11A FXR1 MAP1B AHNAK RSF1 MKI67 ANKRD17 SMARCC2 CCAR2 RAI14 NOP2 MED12 | 8.88e-07 | 1353 | 96 | 16 | 29467282 |
| Pubmed | 1.06e-06 | 191 | 96 | 7 | 31177093 | ||
| Pubmed | 1.06e-06 | 191 | 96 | 7 | 20195357 | ||
| Pubmed | Critical role of the BAF chromatin remodeling complex during murine neural crest development. | 1.13e-06 | 8 | 96 | 3 | 33750945 | |
| Pubmed | ADGB NCOR2 PPRC1 TEX2 G3BP2 MKI67 NASP KDM2B SMARCE1 CACNA1G NOP2 FSCB | 1.17e-06 | 754 | 96 | 12 | 35906200 | |
| Pubmed | 1.22e-06 | 67 | 96 | 5 | 29254152 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | THOC1 WDR3 ZC3H11A FXR1 MAP7D3 MAP1B G3BP2 MKI67 CCAR2 SARNP NOP2 MED12 | 1.25e-06 | 759 | 96 | 12 | 35915203 |
| Pubmed | RTF1 SRRM1 BRD8 MKI67 NUCKS1 NASP SMARCC2 SMARCE1 RAI14 NOP2 | 1.43e-06 | 506 | 96 | 10 | 30890647 | |
| Pubmed | The functional interactome landscape of the human histone deacetylase family. | 1.45e-06 | 289 | 96 | 8 | 23752268 | |
| Pubmed | NCOR2 MAP7D3 G3BP2 BCORL1 RSF1 KDM2B ANKRD17 SMARCC2 SMARCE1 INTS3 SPEN | 1.56e-06 | 638 | 96 | 11 | 31182584 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | 1.66e-06 | 398 | 96 | 9 | 35016035 | |
| Pubmed | OGFRL1 RCOR1 ZC3H11A BRD8 FXR1 ANK3 EPB41L4B PPRC1 TEX2 NASP ANKRD17 SRGAP2 SUCO AKAP12 | 1.67e-06 | 1084 | 96 | 14 | 11544199 | |
| Pubmed | 1.69e-06 | 9 | 96 | 3 | 30355451 | ||
| Pubmed | 1.83e-06 | 298 | 96 | 8 | 30737378 | ||
| Pubmed | 2.00e-06 | 210 | 96 | 7 | 16565220 | ||
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 2.16e-06 | 411 | 96 | 9 | 35182466 | |
| Pubmed | SRRM1 NCOR2 RCOR1 ZMYND11 BRD8 FXR1 ZNF618 KDM5C RSF1 ANKRD17 SMARCC2 SMARCE1 ZZEF1 NSD3 | 2.34e-06 | 1116 | 96 | 14 | 31753913 | |
| Pubmed | 2.41e-06 | 10 | 96 | 3 | 18265020 | ||
| Pubmed | 2.41e-06 | 216 | 96 | 7 | 31519766 | ||
| Pubmed | 2.60e-06 | 78 | 96 | 5 | 28611094 | ||
| Pubmed | WDR3 SLK LMAN1 MAP7D3 AHNAK MKI67 SPART SMARCC2 CCAR2 RAI14 RP9 SARNP AKAP12 NSD3 CCNB1 | 2.67e-06 | 1297 | 96 | 15 | 33545068 | |
| Pubmed | 3.53e-06 | 83 | 96 | 5 | 28794006 | ||
| Pubmed | 3.82e-06 | 441 | 96 | 9 | 31239290 | ||
| Pubmed | 3.88e-06 | 330 | 96 | 8 | 32529326 | ||
| Pubmed | 4.00e-06 | 568 | 96 | 10 | 37774976 | ||
| Pubmed | 4.09e-06 | 234 | 96 | 7 | 36243803 | ||
| Pubmed | 4.21e-06 | 86 | 96 | 5 | 37253089 | ||
| Pubmed | RANBP2 LMAN1 ANK3 MAP7D3 MAP1B AHNAK SPART ANKRD17 RAI14 MED12 AKAP12 | 4.23e-06 | 708 | 96 | 11 | 39231216 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | THOC1 WDR3 SRRM1 RANBP2 ZC3H11A FXR1 MAP1B AHNAK MKI67 SMARCC2 CCAR2 SPEN NOP2 | 4.89e-06 | 1024 | 96 | 13 | 24711643 |
| Pubmed | 5.71e-06 | 13 | 96 | 3 | 15931389 | ||
| Pubmed | Pioneering axons regulate neuronal polarization in the developing cerebral cortex. | 5.71e-06 | 13 | 96 | 3 | 24559674 | |
| Pubmed | PPP4R3B NCOR2 RANBP2 LMAN1 ANK3 PTPRK AHNAK MKI67 NUCKS1 CCAR2 RAI14 LTBP1 NSD3 | 6.33e-06 | 1049 | 96 | 13 | 27880917 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 19164553 | ||
| Pubmed | RANBP2-ALK fusion combined with monosomy 7 in acute myelomonocytic leukemia. | 7.54e-06 | 2 | 96 | 2 | 24613277 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 1769342 | ||
| Pubmed | Smooth muscle-specific genes are differentially sensitive to inhibition by Elk-1. | 7.54e-06 | 2 | 96 | 2 | 16260603 | |
| Pubmed | 7.54e-06 | 2 | 96 | 2 | 9435219 | ||
| Pubmed | Identification of RANBP2-ALK fusion in ALK positive diffuse large B-cell lymphoma. | 7.54e-06 | 2 | 96 | 2 | 24470379 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | THOC1 WDR3 RANBP2 SLK ZC3H11A FXR1 LMAN1 G3BP2 MKI67 NUCKS1 NASP SMARCE1 CCAR2 SPEN NOP2 | 8.28e-06 | 1425 | 96 | 15 | 30948266 |
| Pubmed | 9.72e-06 | 102 | 96 | 5 | 9734811 | ||
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 1.05e-05 | 178 | 96 | 6 | 27637333 | |
| Pubmed | 1.11e-05 | 16 | 96 | 3 | 37522516 | ||
| Pubmed | 1.35e-05 | 653 | 96 | 10 | 33742100 | ||
| Pubmed | Identification of a polymorphic, neuron-specific chromatin remodeling complex. | 1.35e-05 | 17 | 96 | 3 | 12368262 | |
| Pubmed | Phosphoproteomic analysis of synaptosomes from human cerebral cortex. | 1.35e-05 | 17 | 96 | 3 | 15822905 | |
| Pubmed | 1.38e-05 | 282 | 96 | 7 | 23667531 | ||
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 1.41e-05 | 283 | 96 | 7 | 30585729 | |
| Pubmed | Sox2 cooperates with Chd7 to regulate genes that are mutated in human syndromes. | 1.44e-05 | 53 | 96 | 4 | 21532573 | |
| Pubmed | 1.47e-05 | 660 | 96 | 10 | 32780723 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | 1.57e-05 | 665 | 96 | 10 | 30457570 | |
| Pubmed | 1.61e-05 | 18 | 96 | 3 | 22837015 | ||
| Pubmed | RTF1 RLF SRRM1 ZC3H11A BRD8 FXR1 KDM5C NASP ANKRD17 ELK1 LTBP1 NOP2 MED12 MTFMT | 1.67e-05 | 1327 | 96 | 14 | 32694731 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 1.73e-05 | 533 | 96 | 9 | 30554943 | |
| Pubmed | Neddylation modification of the U3 snoRNA-binding protein RRP9 by Smurf1 promotes tumorigenesis. | 1.89e-05 | 117 | 96 | 5 | 34662580 | |
| Pubmed | 1.91e-05 | 19 | 96 | 3 | 31186351 | ||
| Pubmed | 1.91e-05 | 19 | 96 | 3 | 17554007 | ||
| Pubmed | 1.97e-05 | 118 | 96 | 5 | 30979931 | ||
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 2.20e-05 | 203 | 96 | 6 | 22083510 | |
| Pubmed | An epigenetic circuit controls neurogenic programs during neocortex development. | 2.25e-05 | 20 | 96 | 3 | 35020876 | |
| Pubmed | 2.25e-05 | 20 | 96 | 3 | 33397958 | ||
| Interaction | RCOR1 interactions | RLF NEFM NCOR2 RANBP2 RCOR1 LMAN1 AHNAK BCORL1 MKI67 NUCKS1 KDM2B ANKRD17 SMARCC2 SMARCE1 RAI14 SPEN MED12 | 1.66e-10 | 494 | 96 | 17 | int:RCOR1 |
| Interaction | HDAC1 interactions | TRERF1 RLF NEFM NCOR2 RANBP2 RCOR1 ZMYND11 TNRC18 LMAN1 KDM5C AHNAK MKI67 NUCKS1 KDM2B GON4L ANKRD17 SMARCC2 SMARCE1 CCAR2 RAI14 ELK1 SPEN MED12 CCNB1 | 2.64e-10 | 1108 | 96 | 24 | int:HDAC1 |
| Interaction | TERF2IP interactions | THOC1 RTF1 NCOR2 RCOR1 ZC3H11A BRD8 KDM5C RSF1 MKI67 NUCKS1 NASP KDM2B SMARCC2 SARNP SPEN WIPI2 NSD3 | 9.06e-10 | 552 | 96 | 17 | int:TERF2IP |
| Interaction | H2BC8 interactions | RTF1 RLF RCOR1 BRD8 BCORL1 RSF1 MKI67 NUCKS1 KDM2B GON4L SMARCC2 SMARCE1 RP9 INTS3 SARNP SPEN NSD3 | 1.72e-09 | 576 | 96 | 17 | int:H2BC8 |
| Interaction | CEBPA interactions | THOC1 TRERF1 RLF PPP4R3B ATF7 NCOR2 RANBP2 MED6 RCOR1 TNRC18 ZC3H11A LMAN1 G3BP2 BCORL1 MKI67 NUCKS1 SMARCC2 SMARCE1 CCAR2 SARNP SPEN NOP2 MED12 CCNB1 | 2.72e-09 | 1245 | 96 | 24 | int:CEBPA |
| Interaction | NUP43 interactions | RTF1 RLF WDR3 SRRM1 NCOR2 RANBP2 BRD8 DSCAM KDM5C RSF1 MKI67 GON4L SMARCE1 CCAR2 SPEN MED12 NSD3 | 5.85e-09 | 625 | 96 | 17 | int:NUP43 |
| Interaction | SMC5 interactions | THOC1 WDR3 SRRM1 NCOR2 RANBP2 ZC3H11A BRD8 MAP7D3 MAP1B AHNAK BCORL1 RSF1 MKI67 SMARCC2 SMARCE1 RP9 SARNP SPEN NOP2 ALK NSD3 | 7.42e-09 | 1000 | 96 | 21 | int:SMC5 |
| Interaction | SIRT7 interactions | NEFM WDR3 SRRM1 RANBP2 ZC3H11A FXR1 MAP1B AHNAK RSF1 MKI67 ANKRD17 SMARCC2 CCAR2 SPEN NOP2 MED12 CCNB1 | 7.46e-08 | 744 | 96 | 17 | int:SIRT7 |
| Interaction | YAP1 interactions | RTF1 TRERF1 NEFM TNRC18 SLK ZC3H11A BRD8 FXR1 ANK3 MAP7D3 AHNAK NASP KDM2B SMARCC2 SMARCE1 RAI14 SPEN SH3D21 MED12 NSD3 | 1.77e-07 | 1095 | 96 | 20 | int:YAP1 |
| Interaction | CBX3 interactions | RTF1 RLF WDR3 SRRM1 KDM5C BCORL1 RSF1 MKI67 NUCKS1 KDM2B SMARCE1 RP9 SPEN NSD3 TGOLN2 | 3.90e-07 | 646 | 96 | 15 | int:CBX3 |
| Interaction | BAP1 interactions | NEFM SRRM1 RANBP2 RCOR1 SLK FXR1 ANK3 MAP1B KDM5C AHNAK G3BP2 NUCKS1 NASP SPART ANKRD17 CCAR2 RAI14 SRGAP2 SARNP SUCO AKAP12 | 7.50e-07 | 1314 | 96 | 21 | int:BAP1 |
| Interaction | H2BC21 interactions | RTF1 RLF RCOR1 MAP1B AHNAK BCORL1 RSF1 MKI67 NUCKS1 SMARCC2 SMARCE1 SMG5 INTS3 NOP2 NSD3 | 9.96e-07 | 696 | 96 | 15 | int:H2BC21 |
| Interaction | H3C1 interactions | RLF RCOR1 ZMYND11 TNRC18 ANK3 AHNAK RSF1 MKI67 NUCKS1 NASP KDM2B SMARCC2 ZZEF1 SARNP SPEN NOP2 NSD3 | 1.10e-06 | 901 | 96 | 17 | int:H3C1 |
| Interaction | MED4 interactions | THOC1 SRRM1 MED6 SLK MAP7D3 MAP1B AHNAK SMARCE1 RAI14 SKA1 NOP2 MED12 | 1.52e-06 | 450 | 96 | 12 | int:MED4 |
| Interaction | NUMA1 interactions | RTF1 RLF SRRM1 RANBP2 RCOR1 RSF1 MKI67 NUCKS1 SMARCE1 INTS3 MED12 CCNB1 | 2.33e-06 | 469 | 96 | 12 | int:NUMA1 |
| Interaction | FOS interactions | NEFM ATF7 NCOR2 MAP1B KDM2B ANKRD17 SMARCC2 SMARCE1 RAI14 ELK1 | 2.38e-06 | 312 | 96 | 10 | int:FOS |
| Interaction | NAA40 interactions | RANBP2 SLK ZC3H11A MAP7D3 MAP1B AHNAK RSF1 MKI67 NUCKS1 NASP SPART ANKRD17 SMARCE1 RAI14 SRGAP2 NOP2 AKAP12 | 3.33e-06 | 978 | 96 | 17 | int:NAA40 |
| Interaction | CEBPB interactions | THOC1 RTF1 ATF7 SRRM1 NCOR2 RANBP2 RCOR1 ZC3H11A BRD8 AHNAK G3BP2 RSF1 MKI67 NASP SPART SMARCC2 SMARCE1 ELK1 RP9 SARNP NOP2 | 3.35e-06 | 1443 | 96 | 21 | int:CEBPB |
| Interaction | H3C3 interactions | RLF SRRM1 BCORL1 RSF1 MKI67 NASP KDM2B SMARCC2 SMARCE1 SPEN NOP2 NSD3 | 4.06e-06 | 495 | 96 | 12 | int:H3C3 |
| Interaction | TRRAP interactions | RTF1 ADGB NCOR2 BRD8 PPRC1 TEX2 KDM5C G3BP2 MKI67 NASP SMARCE1 CACNA1G NOP2 FSCB MED12 | 4.72e-06 | 790 | 96 | 15 | int:TRRAP |
| Interaction | UHRF2 interactions | 5.14e-06 | 200 | 96 | 8 | int:UHRF2 | |
| Interaction | THOC1 interactions | 7.35e-06 | 210 | 96 | 8 | int:THOC1 | |
| Interaction | BAG2 interactions | RTF1 SLK BRD8 LMAN1 MAP1B TEX2 AHNAK BCORL1 CCAR2 ELK1 SPEN SKA1 MED12 | 7.84e-06 | 622 | 96 | 13 | int:BAG2 |
| Interaction | SIRT6 interactions | WDR3 PPP4R3B RANBP2 FXR1 G3BP2 HECTD4 MKI67 ANKRD17 SMARCC2 CCAR2 SARNP NOP2 MED12 | 8.68e-06 | 628 | 96 | 13 | int:SIRT6 |
| Interaction | SOX2 interactions | TRERF1 RLF WDR3 NCOR2 RANBP2 RCOR1 TNRC18 BRD8 CHMP4A MAP1B G3BP2 KDM2B ANKRD17 SMARCC2 SMARCE1 CCAR2 RAI14 INTS3 SPEN NOP2 | 9.99e-06 | 1422 | 96 | 20 | int:SOX2 |
| Interaction | SNRNP40 interactions | WDR3 SRRM1 NCOR2 G3BP2 RSF1 MKI67 GON4L SMARCC2 CCAR2 RP9 SPEN MED12 NSD3 | 1.01e-05 | 637 | 96 | 13 | int:SNRNP40 |
| Interaction | PRMT5 interactions | WDR3 PPP4R3B NCOR2 RANBP2 G3BP2 NASP KDM2B SMARCC2 SMARCE1 CCAR2 TGOLN2 | 1.49e-05 | 471 | 96 | 11 | int:PRMT5 |
| Interaction | ARL14 interactions | 2.24e-05 | 119 | 96 | 6 | int:ARL14 | |
| Interaction | EWSR1 interactions | PRUNE2 SRRM1 BRD8 KDM5C BCORL1 RSF1 MKI67 NUCKS1 SMARCC2 SMARCE1 CCAR2 RAI14 ELK1 SARNP TGOLN2 | 2.39e-05 | 906 | 96 | 15 | int:EWSR1 |
| Interaction | RNF113A interactions | TRERF1 PPP4R3B SRRM1 NCOR2 RANBP2 RCOR1 TNRC18 FXR1 G3BP2 MKI67 ANKRD17 RP9 NOP2 | 2.42e-05 | 692 | 96 | 13 | int:RNF113A |
| Interaction | DOT1L interactions | WDR3 SRRM1 RANBP2 ZC3H11A FXR1 G3BP2 MKI67 SMARCC2 SMARCE1 RAI14 SRGAP2 SARNP NOP2 NSD3 | 2.77e-05 | 807 | 96 | 14 | int:DOT1L |
| Interaction | CRX interactions | 2.91e-05 | 254 | 96 | 8 | int:CRX | |
| Interaction | MECP2 interactions | THOC1 NEFM SRRM1 RANBP2 RCOR1 MAP1B ZNF618 HECTD4 MKI67 NUCKS1 SMARCC2 SMARCE1 UPF3A SARNP SPEN NOP2 MED12 NSD3 | 3.23e-05 | 1287 | 96 | 18 | int:MECP2 |
| Interaction | KDM1A interactions | TRERF1 KIAA0408 RLF NEFM NCOR2 RANBP2 RCOR1 LMAN1 AHNAK BCORL1 KDM2B ANKRD17 SMARCC2 RAI14 MED12 | 3.70e-05 | 941 | 96 | 15 | int:KDM1A |
| Interaction | PHF21A interactions | 3.81e-05 | 343 | 96 | 9 | int:PHF21A | |
| Interaction | MIER1 interactions | 4.00e-05 | 80 | 96 | 5 | int:MIER1 | |
| Interaction | FOXP3 interactions | WDR3 SRRM1 RANBP2 RCOR1 SMARCC2 SMARCE1 CCAR2 INTS3 NSD3 CCNB1 | 4.03e-05 | 432 | 96 | 10 | int:FOXP3 |
| Interaction | TRIM37 interactions | KIAA0408 NCOR2 ZC3H11A FXR1 MAP7D3 DSCAM PTPRK AHNAK MKI67 CCAR2 SPEN CCNB1 | 4.46e-05 | 630 | 96 | 12 | int:TRIM37 |
| Interaction | SOX7 interactions | 4.51e-05 | 82 | 96 | 5 | int:SOX7 | |
| Interaction | CIT interactions | THOC1 NEFM WDR3 SRRM1 RANBP2 FXR1 LMAN1 DSCAM AHNAK G3BP2 RSF1 MKI67 SMARCC2 CCAR2 RAI14 RP9 ZZEF1 SARNP NOP2 | 4.60e-05 | 1450 | 96 | 19 | int:CIT |
| Interaction | FMR1 interactions | THOC1 NCOR2 RANBP2 FXR1 MAP1B AHNAK G3BP2 MKI67 ANKRD17 SMARCC2 CCAR2 | 4.87e-05 | 536 | 96 | 11 | int:FMR1 |
| Interaction | E2F4 interactions | THOC1 SRRM1 NCOR2 ZC3H11A FXR1 MYLK ANK3 NASP SMARCC2 SMARCE1 SARNP | 5.21e-05 | 540 | 96 | 11 | int:E2F4 |
| Interaction | MYH9 interactions | NEFM WDR3 RCOR1 TNRC18 FXR1 MYLK MAP1B TEX2 AHNAK NASP RAI14 ALK TGOLN2 | 5.85e-05 | 754 | 96 | 13 | int:MYH9 |
| Interaction | HECTD1 interactions | THOC1 WDR3 MED6 ZC3H11A FXR1 MAP7D3 MAP1B G3BP2 MKI67 CCAR2 SRGAP2 SARNP NOP2 MED12 TGOLN2 | 6.16e-05 | 984 | 96 | 15 | int:HECTD1 |
| Interaction | AURKB interactions | SRRM1 RANBP2 RCOR1 FXR1 MAP1B AHNAK G3BP2 MKI67 ANKRD17 ZZEF1 SKA1 NOP2 TXNDC2 | 6.43e-05 | 761 | 96 | 13 | int:AURKB |
| Interaction | SMARCA4 interactions | NCOR2 MED6 RCOR1 ZMYND11 FXR1 KDM5C NUCKS1 SMARCC2 SMARCE1 NSD3 | 7.06e-05 | 462 | 96 | 10 | int:SMARCA4 |
| Interaction | MYCN interactions | THOC1 NEFM WDR3 SRRM1 ZC3H11A FXR1 CHMP4A MAP1B G3BP2 MKI67 ANKRD17 SMARCC2 SMARCE1 CCAR2 RP9 SARNP NOP2 SLC1A2 | 7.50e-05 | 1373 | 96 | 18 | int:MYCN |
| Interaction | CMTR1 interactions | 8.30e-05 | 218 | 96 | 7 | int:CMTR1 | |
| Interaction | FXR1 interactions | THOC1 NEFM NCOR2 RANBP2 FXR1 G3BP2 ANKRD17 SMARCC2 CCAR2 SMG5 NOP2 CCNB1 | 9.13e-05 | 679 | 96 | 12 | int:FXR1 |
| Interaction | ABI1 interactions | 9.56e-05 | 223 | 96 | 7 | int:ABI1 | |
| Interaction | MEN1 interactions | THOC1 WDR3 ATF7 SRRM1 ZC3H11A FXR1 G3BP2 MKI67 ANKRD17 SMARCC2 SMARCE1 SPEN NOP2 MED12 NSD3 | 1.02e-04 | 1029 | 96 | 15 | int:MEN1 |
| Interaction | CHMP4C interactions | WDR3 FXR1 CHMP4A LMAN1 AHNAK RSF1 MKI67 NUCKS1 NASP RAI14 LTBP1 NOP2 | 1.02e-04 | 687 | 96 | 12 | int:CHMP4C |
| Interaction | PSMC5 interactions | 1.04e-04 | 484 | 96 | 10 | int:PSMC5 | |
| Interaction | NLE1 interactions | 1.10e-04 | 228 | 96 | 7 | int:NLE1 | |
| Interaction | TEX13B interactions | 1.13e-04 | 20 | 96 | 3 | int:TEX13B | |
| Interaction | FUBP1 interactions | 1.15e-04 | 309 | 96 | 8 | int:FUBP1 | |
| Interaction | GRB10 interactions | 1.21e-04 | 161 | 96 | 6 | int:GRB10 | |
| Interaction | KIF20A interactions | NEFM WDR3 SRRM1 RANBP2 FXR1 CHMP4A AHNAK G3BP2 HECTD4 MKI67 NUCKS1 SMARCC2 RAI14 NOP2 NSD3 | 1.30e-04 | 1052 | 96 | 15 | int:KIF20A |
| Interaction | CHD4 interactions | THOC1 WDR3 SRRM1 RCOR1 SLK AHNAK RSF1 MKI67 NASP SMARCC2 SMARCE1 CCAR2 SPEN NOP2 | 1.39e-04 | 938 | 96 | 14 | int:CHD4 |
| Interaction | PARP1 interactions | RTF1 RLF WDR3 SRRM1 BPNT2 MED6 BCORL1 RSF1 MKI67 NUCKS1 KDM2B SMARCC2 SMARCE1 CCAR2 NOP2 NSD3 CCNB1 | 1.46e-04 | 1316 | 96 | 17 | int:PARP1 |
| Interaction | TPRX2 interactions | 1.47e-04 | 56 | 96 | 4 | int:TPRX2 | |
| Interaction | PPP1R12A interactions | 1.53e-04 | 322 | 96 | 8 | int:PPP1R12A | |
| Interaction | RHBDF2 interactions | 1.53e-04 | 168 | 96 | 6 | int:RHBDF2 | |
| Interaction | ZC3H14 interactions | 1.58e-04 | 169 | 96 | 6 | int:ZC3H14 | |
| Interaction | KLF8 interactions | 1.77e-04 | 329 | 96 | 8 | int:KLF8 | |
| Interaction | ASF1A interactions | 1.89e-04 | 249 | 96 | 7 | int:ASF1A | |
| Interaction | PHLPP1 interactions | 1.92e-04 | 333 | 96 | 8 | int:PHLPP1 | |
| Interaction | MED12 interactions | 1.97e-04 | 176 | 96 | 6 | int:MED12 | |
| Interaction | PRC1 interactions | THOC1 WDR3 SRRM1 RANBP2 FXR1 AHNAK G3BP2 RSF1 MKI67 RAI14 ZZEF1 SPEN NOP2 CCNB1 | 2.03e-04 | 973 | 96 | 14 | int:PRC1 |
| Interaction | RBPJ interactions | 2.14e-04 | 254 | 96 | 7 | int:RBPJ | |
| Interaction | PPP4R3A interactions | 2.16e-04 | 179 | 96 | 6 | int:PPP4R3A | |
| Interaction | H3-3A interactions | RLF ZMYND11 KDM5C BCORL1 RSF1 MKI67 NASP KDM2B SMARCC2 SMARCE1 SPEN NSD3 | 2.27e-04 | 749 | 96 | 12 | int:H3-3A |
| Interaction | RNF2 interactions | THOC1 RANBP2 BRD8 ANK3 KDM5C G3BP2 BCORL1 RSF1 MKI67 KDM2B SMARCC2 SMARCE1 NOP2 | 2.32e-04 | 866 | 96 | 13 | int:RNF2 |
| Interaction | TBXT interactions | 2.33e-04 | 116 | 96 | 5 | int:TBXT | |
| Interaction | LHX2 interactions | 2.43e-04 | 183 | 96 | 6 | int:LHX2 | |
| Interaction | SUZ12 interactions | RANBP2 MED6 RCOR1 FXR1 G3BP2 MKI67 NUCKS1 SMARCC2 CCAR2 INTS3 NOP2 | 2.45e-04 | 644 | 96 | 11 | int:SUZ12 |
| Interaction | KCNA3 interactions | SRRM1 RANBP2 LMAN1 ANK3 MAP7D3 MAP1B AHNAK SPART ANKRD17 RAI14 SPEN MED12 AKAP12 | 2.45e-04 | 871 | 96 | 13 | int:KCNA3 |
| Interaction | FAM110D interactions | 2.52e-04 | 26 | 96 | 3 | int:FAM110D | |
| Interaction | ZNF330 interactions | 2.78e-04 | 446 | 96 | 9 | int:ZNF330 | |
| Interaction | TOP2B interactions | 2.83e-04 | 266 | 96 | 7 | int:TOP2B | |
| Interaction | HSPA13 interactions | 2.95e-04 | 122 | 96 | 5 | int:HSPA13 | |
| Interaction | MYCBP2 interactions | 2.95e-04 | 355 | 96 | 8 | int:MYCBP2 | |
| Interaction | BMI1 interactions | SRRM1 RANBP2 ZC3H11A FXR1 G3BP2 BCORL1 MKI67 KDM2B SPEN NOP2 MED12 | 2.98e-04 | 659 | 96 | 11 | int:BMI1 |
| Interaction | RABGAP1 interactions | 3.30e-04 | 125 | 96 | 5 | int:RABGAP1 | |
| Interaction | RNF4 interactions | RLF WDR3 PPP4R3B NCOR2 RANBP2 ZMYND11 LMAN1 PTPRK ZNF618 AHNAK RSF1 MKI67 SMARCC2 NCAM1 INTS3 NOP2 MED12 | 3.36e-04 | 1412 | 96 | 17 | int:RNF4 |
| Interaction | TNK2 interactions | 3.42e-04 | 195 | 96 | 6 | int:TNK2 | |
| Interaction | NCOR1 interactions | 3.43e-04 | 363 | 96 | 8 | int:NCOR1 | |
| Interaction | OBSL1 interactions | THOC1 PRUNE2 WDR3 SRRM1 RANBP2 ZC3H11A AHNAK G3BP2 MKI67 SMARCC2 CCAR2 SPEN NOP2 | 3.43e-04 | 902 | 96 | 13 | int:OBSL1 |
| Interaction | SRCAP interactions | 3.55e-04 | 127 | 96 | 5 | int:SRCAP | |
| Interaction | RBBP4 interactions | RCOR1 TNRC18 NUCKS1 NASP KDM2B SMARCC2 SMARCE1 INTS3 SPEN TGOLN2 | 4.02e-04 | 573 | 96 | 10 | int:RBBP4 |
| Interaction | SSRP1 interactions | THOC1 RTF1 RLF SRRM1 RANBP2 ZC3H11A RSF1 UPF3A INTS3 NOP2 TXNDC2 | 4.13e-04 | 685 | 96 | 11 | int:SSRP1 |
| Interaction | TLE3 interactions | 4.33e-04 | 376 | 96 | 8 | int:TLE3 | |
| Interaction | PDCD6 interactions | 4.35e-04 | 204 | 96 | 6 | int:PDCD6 | |
| Interaction | GUSBP5 interactions | 4.54e-04 | 75 | 96 | 4 | int:GUSBP5 | |
| Interaction | CBX1 interactions | 4.56e-04 | 288 | 96 | 7 | int:CBX1 | |
| Interaction | ACTC1 interactions | RTF1 SRRM1 BRD8 MYLK MKI67 NUCKS1 NASP SMARCC2 SMARCE1 RAI14 NOP2 | 4.61e-04 | 694 | 96 | 11 | int:ACTC1 |
| Interaction | RBMS1 interactions | 4.70e-04 | 207 | 96 | 6 | int:RBMS1 | |
| Interaction | TNIK interactions | 4.73e-04 | 381 | 96 | 8 | int:TNIK | |
| Interaction | NANOG interactions | 4.82e-04 | 481 | 96 | 9 | int:NANOG | |
| Interaction | ARL4C interactions | 4.86e-04 | 136 | 96 | 5 | int:ARL4C | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 1.39e-06 | 53 | 66 | 5 | 532 | |
| GeneFamily | PHD finger proteins | 1.92e-05 | 90 | 66 | 5 | 88 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 1.01e-04 | 25 | 66 | 3 | 775 | |
| GeneFamily | Fibronectin type III domain containing | 2.95e-04 | 160 | 66 | 5 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.84e-03 | 161 | 66 | 4 | 593 | |
| GeneFamily | PWWP domain containing | 2.89e-03 | 22 | 66 | 2 | 1147 | |
| GeneFamily | PHD finger proteins|Lysine demethylases | 3.44e-03 | 24 | 66 | 2 | 485 | |
| GeneFamily | Cyclins|Mediator complex | 6.44e-03 | 33 | 66 | 2 | 1061 | |
| GeneFamily | Zinc fingers CCCH-type | 7.23e-03 | 35 | 66 | 2 | 73 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RLF NCOR2 RANBP2 RCOR1 ZMYND11 SLK FXR1 MAP1B PTPRK SPART ANKRD17 SRGAP2 ZZEF1 SPEN SUCO | 5.06e-07 | 856 | 96 | 15 | M4500 |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 9.32e-07 | 206 | 96 | 8 | M2817 | |
| Coexpression | STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP | 1.00e-06 | 208 | 96 | 8 | MM581 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | PRUNE2 NEFM NCOR2 RANBP2 ZMYND11 SLK FXR1 LMAN1 MAP1B G3BP2 HECTD4 NUCKS1 SUCO TGOLN2 | 8.84e-06 | 946 | 96 | 14 | M39169 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 2.04e-05 | 90 | 96 | 5 | M39250 | |
| Coexpression | RODRIGUES_NTN1_TARGETS_DN | 2.87e-05 | 161 | 96 | 6 | M11857 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | TNRC18 LMAN1 PTPRK TEX2 NCAM1 LTBP1 ZZEF1 SUCO PCDH1 GRAMD4 TGOLN2 | 4.00e-05 | 681 | 96 | 11 | M5314 |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | THOC1 WDR3 RANBP2 ZC3H11A FXR1 LMAN1 PPRC1 ZNF618 MKI67 NUCKS1 SMARCE1 RAI14 SARNP NOP2 NSD3 CCNB1 | 4.95e-05 | 1407 | 96 | 16 | M14427 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | TNRC18 LMAN1 PTPRK TEX2 NCAM1 LTBP1 ZZEF1 SUCO PCDH1 GRAMD4 TGOLN2 | 5.33e-05 | 703 | 96 | 11 | MM1055 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 5.43e-05 | 466 | 96 | 9 | M13522 | |
| Coexpression | GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN | 8.35e-05 | 195 | 96 | 6 | M7382 | |
| Coexpression | NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP | 8.53e-05 | 284 | 96 | 7 | M16975 | |
| Coexpression | GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_DN | 9.08e-05 | 198 | 96 | 6 | M7249 | |
| Coexpression | GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP | 9.60e-05 | 200 | 96 | 6 | M5066 | |
| Coexpression | GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_UP | 9.60e-05 | 200 | 96 | 6 | M9776 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP | 9.60e-05 | 200 | 96 | 6 | M9831 | |
| Coexpression | CROONQUIST_NRAS_SIGNALING_DN | 1.29e-04 | 70 | 96 | 4 | M10739 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000 | SRRM1 BPNT2 TNRC18 ZC3H11A PTPRK ZNF618 KDM5C NASP ELK1 WIPI2 NSD3 | 6.51e-08 | 284 | 96 | 11 | gudmap_developingGonad_e16.5_epididymis_1000_k2 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | RLF SRRM1 BPNT2 TNRC18 ZC3H11A LMAN1 MYLK PTPRK ZNF618 KDM5C BCORL1 NASP NCAM1 ELK1 WIPI2 NSD3 | 4.76e-07 | 790 | 96 | 16 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | RLF SRRM1 BPNT2 TNRC18 ZC3H11A LMAN1 PTPRK ZNF618 KDM5C G3BP2 BCORL1 NASP NCAM1 ELK1 WIPI2 NSD3 | 5.71e-07 | 801 | 96 | 16 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.36e-06 | 275 | 96 | 9 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500 | 8.91e-06 | 162 | 96 | 7 | gudmap_developingGonad_e16.5_epididymis_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.81e-06 | 230 | 96 | 8 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.31e-05 | 259 | 96 | 8 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 4.13e-05 | 281 | 96 | 8 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | THOC1 NEFM PPP4R3B SRRM1 OGFRL1 MED6 ZNF618 RSF1 MKI67 NASP SMARCC2 SMARCE1 CACNA1G ELK1 SARNP SKA1 NSD3 | 4.19e-05 | 1252 | 96 | 17 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.74e-05 | 210 | 96 | 7 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | RLF NEFM SRRM1 TNRC18 ZC3H11A PTPRK ZNF618 G3BP2 RSF1 NASP ANKRD17 WIPI2 NSD3 | 6.79e-05 | 806 | 96 | 13 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e13.5_podocyte cells_emap-27773_k-means-cluster#4_top-relative-expression-ranked_1000 | 8.40e-05 | 311 | 96 | 8 | gudmap_developingKidney_e13.5_podocyte cells_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_500 | 8.63e-05 | 231 | 96 | 7 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.09e-04 | 323 | 96 | 8 | gudmap_developingGonad_e11.5_ovary + mesonephros_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.38e-04 | 249 | 96 | 7 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.47e-04 | 532 | 96 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000 | 2.64e-04 | 277 | 96 | 7 | gudmap_developingGonad_e12.5_ovary_k3_1000 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_1000 | KIAA0408 RLF NEFM SRRM1 ZC3H11A BRD8 MAP1B ZNF618 G3BP2 NASP WIPI2 NSD3 | 3.06e-04 | 815 | 96 | 12 | gudmap_developingGonad_e11.5_ovary + mesonephros_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes_emap-3226_k-means-cluster#2_top-relative-expression-ranked_500 | 3.22e-04 | 203 | 96 | 6 | gudmap_developingGonad_e11.5_testes_k2_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.30e-04 | 204 | 96 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 5.10e-04 | 406 | 96 | 8 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_500 | 5.65e-04 | 148 | 96 | 5 | gudmap_developingKidney_e12.5_renal vesicle_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500 | 6.00e-04 | 150 | 96 | 5 | gudmap_developingGonad_e12.5_epididymis_k5_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.62e-04 | 323 | 96 | 7 | gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000_k5 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 5.03e-10 | 199 | 96 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 6.74e-10 | 138 | 96 | 8 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.26e-08 | 200 | 96 | 8 | c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-07 | 174 | 96 | 7 | 9d5dcd46cf346c381dea68ada6665f7fb68114a3 | |
| ToppCell | facs-Marrow-KLS-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-07 | 174 | 96 | 7 | 53cec5c666c45278a71c21dd9c62a052a97e0fdf | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.07e-07 | 193 | 96 | 7 | b1893193766ae41bf2ab6ed4083285c9c814e608 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.14e-07 | 194 | 96 | 7 | bea369e9a7018d862e4d7f1c9ec2de50f3fd38ec | |
| ToppCell | LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.63e-07 | 200 | 96 | 7 | 8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 183 | 96 | 6 | ad7421623e4c0c5ba02eec56e9bdae43ebb88d90 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 2.85e-06 | 183 | 96 | 6 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.44e-06 | 189 | 96 | 6 | d049f33115610bda4489968759f754730698b9cd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-06 | 194 | 96 | 6 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.99e-06 | 194 | 96 | 6 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.99e-06 | 194 | 96 | 6 | 490645bfe9ed3dac03c191c7094df01c780b377e | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 195 | 96 | 6 | 803f714d91f2d97ecbee8c15a5139fd9310f66c7 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-06 | 195 | 96 | 6 | 7ae732f100e9a3c6062be5b877efa1ec9d5b3958 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.11e-06 | 195 | 96 | 6 | 4f70157d42a16ff0259bc24a62803c4df4285c44 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.11e-06 | 195 | 96 | 6 | 26a3a5daf389606ef1ebb35533f12e60853b3a12 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.24e-06 | 196 | 96 | 6 | 8faac7fbdee3a9297023c3151ef1751605413e44 | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-06 | 196 | 96 | 6 | ef1482f83872af72a55b6c5b5a1491e6f7f44dd7 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.36e-06 | 197 | 96 | 6 | ba6393671a980a1d439307601d18db70a1b1e1f3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-06 | 197 | 96 | 6 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 4.62e-06 | 199 | 96 | 6 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 4.62e-06 | 199 | 96 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | 4.62e-06 | 199 | 96 | 6 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 | |
| ToppCell | Control-B_intermediate-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.51e-05 | 144 | 96 | 5 | 984470ff6ddce4c743e2db78fa98dae055aaa273 | |
| ToppCell | Pericytes-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.84e-05 | 150 | 96 | 5 | dbc202bd6db4fb5c8b2abd1200e074a2a9e63a59 | |
| ToppCell | Control-B_intermediate-1|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.09e-05 | 167 | 96 | 5 | 948504367ecf58144d9dd74d2ec531358fc4b309 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.46e-05 | 171 | 96 | 5 | b113fbebb89056af0b9c775d2fb6552206a80467 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-05 | 173 | 96 | 5 | c31076c725f4cd912c56903592a2d9356ae59f54 | |
| ToppCell | facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.65e-05 | 173 | 96 | 5 | a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6 | |
| ToppCell | Club-club-15|World / Class top | 3.86e-05 | 175 | 96 | 5 | ca9d012f520f697c7450ec6958a015e20538a6a8 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|World / Stress and Cell class | 3.97e-05 | 176 | 96 | 5 | ce2c32b5ce0da848eb4da35ce4d215cdf74d9113 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.07e-05 | 177 | 96 | 5 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.07e-05 | 177 | 96 | 5 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 4.07e-05 | 177 | 96 | 5 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.07e-05 | 177 | 96 | 5 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.07e-05 | 177 | 96 | 5 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.41e-05 | 180 | 96 | 5 | 5e1680088065be14447d5d5465f91f7edd071a1e | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.41e-05 | 180 | 96 | 5 | d76349ecef7c5878bf215e946f032264161eb61b | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 4.41e-05 | 180 | 96 | 5 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.53e-05 | 181 | 96 | 5 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.53e-05 | 181 | 96 | 5 | ab0f300d14b62cef57f1b0bdae143b8dfe8e6975 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 4.53e-05 | 181 | 96 | 5 | b6b41cd5d43543fe7a093033dae52a789199db0e | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.65e-05 | 182 | 96 | 5 | 37547b36264090b49a193a8ef3a8d88e647f0b79 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-05 | 182 | 96 | 5 | 6fdaf3c8c3952a8f14dd7288e523ed58eb1d3517 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.65e-05 | 182 | 96 | 5 | 7ffb457383da71242e3fbc20dcf6961705a633b0 | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-05 | 183 | 96 | 5 | d26c7b79895de28961b8d68351f28d4bb531c75c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.77e-05 | 183 | 96 | 5 | 61a73de857f4ae02dcba3af348f436f602b28ff2 | |
| ToppCell | 368C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 5.12e-05 | 94 | 96 | 4 | 56176a9435ef197f07034bbbd16b85016a89ad3c | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.16e-05 | 186 | 96 | 5 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.16e-05 | 186 | 96 | 5 | 5d527050cd554cc46c6d8dcb7981900725d79fc6 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_proliferating-Lymphatic_EC_proliferating_L.2.5.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.16e-05 | 186 | 96 | 5 | ee1c3e2adfa2900542200a218746b576c7ed10dc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.29e-05 | 187 | 96 | 5 | 46e15419e80bd7180f3171a99d845b01bb635e53 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 5.29e-05 | 187 | 96 | 5 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.29e-05 | 187 | 96 | 5 | 0d17b07770e4c881a7ca53a5bd42471457d198fb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.29e-05 | 187 | 96 | 5 | 69068480f6819a6c8560ecbb05deb156b4055e12 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.29e-05 | 187 | 96 | 5 | 9c8b932a15b8b50982cba4cf8db750e257eb9503 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 5.43e-05 | 188 | 96 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.43e-05 | 188 | 96 | 5 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.43e-05 | 188 | 96 | 5 | 63773854bf8430fb8229edb385b953a89833d08c | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.43e-05 | 188 | 96 | 5 | 502045a39ffb1e92bd9499848368e8fa971edb88 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.43e-05 | 188 | 96 | 5 | 879de94924de978478696fc7838e05a4d795b905 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.56e-05 | 189 | 96 | 5 | ab7ece0a517499b70b7754720d3e434765363af6 | |
| ToppCell | ILEUM-non-inflamed-(7)_Endothelial_cell-(7)_Lymphatics|(7)_Endothelial_cell / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 5.70e-05 | 190 | 96 | 5 | 9ce301841ce9486701fa28eb2a9929e35d476878 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.70e-05 | 190 | 96 | 5 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.70e-05 | 190 | 96 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.70e-05 | 190 | 96 | 5 | 799351fea7490d4159271d020c43c845ef37c788 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes-Fibromyocytes_L.2.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-05 | 191 | 96 | 5 | d35692c652977500a3c36aa26c347a072b71e441 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-05 | 191 | 96 | 5 | 1cb02007adb344f17ef73d58890f91298c7cf5a1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Fibromyocytes|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.85e-05 | 191 | 96 | 5 | 2a107e9096eb58b81b3da61547904d85754f6b2f | |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.85e-05 | 191 | 96 | 5 | f764cc21fef87ebad765011098f647ae1bdf6158 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l12-14|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.99e-05 | 192 | 96 | 5 | 52d0aa51e3b6ab3608a5f40bdde9f8134b3afd94 | |
| ToppCell | (0)_Normal/No_Treatment-(3)_LEPR+_perivascular_cells|(0)_Normal/No_Treatment / Stress and Cell class | 5.99e-05 | 192 | 96 | 5 | 7a2ad0bdae647b88e799e62767605f2f3c5a426f | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.14e-05 | 193 | 96 | 5 | 173f1d83133f5ffa88e2a75d28835ad7acd2aa90 | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.14e-05 | 193 | 96 | 5 | 1e95ef29357969ee385b4717c0b5a497390ac260 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.14e-05 | 193 | 96 | 5 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.14e-05 | 193 | 96 | 5 | 0f21fb8b35f89f4c1c8109d1a4d3d08a452f9edd | |
| ToppCell | myeloid-CD34+_Myeloblast|myeloid / Lineage and Cell class | 6.30e-05 | 194 | 96 | 5 | 35549e63e8c167e6c4bd76e2d7863d95a3f3c3d5 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.30e-05 | 194 | 96 | 5 | f44394c8a6f86483063f2f5722f003a8a0a70254 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.30e-05 | 194 | 96 | 5 | 93bc72a933ccc6a760e5353f072afb606571c6fc | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.30e-05 | 194 | 96 | 5 | 5d60262a512590d60bc795d9a0e03c0219e3e15e | |
| ToppCell | 18-Airway-Epithelial-Epithelial|Airway / Age, Tissue, Lineage and Cell class | 6.30e-05 | 194 | 96 | 5 | d3c90e1f1228f8ba0ba56105c6cf4f302c388f28 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.45e-05 | 195 | 96 | 5 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.45e-05 | 195 | 96 | 5 | 97b2ff072cc830a4a2cb217f5a215ca6cad505ec | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.45e-05 | 195 | 96 | 5 | 742c82c86487314cdb3178012004adb1164bcbdb | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.45e-05 | 195 | 96 | 5 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 196 | 96 | 5 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 196 | 96 | 5 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 196 | 96 | 5 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 196 | 96 | 5 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.61e-05 | 196 | 96 | 5 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.61e-05 | 196 | 96 | 5 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.61e-05 | 196 | 96 | 5 | 62b2de1d38a99ab23211bf51595845f8a1fdb7d2 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.61e-05 | 196 | 96 | 5 | 5ddd314d3def3776dc7da83778d41c6436ca51ac | |
| ToppCell | myeloid-pro-pDC|myeloid / Lineage and Cell class | 6.61e-05 | 196 | 96 | 5 | 70daf4fabb68aecc5cc9f03d6f6495dd29b74a16 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.77e-05 | 197 | 96 | 5 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-05 | 197 | 96 | 5 | 9b2c67de46bd59bf56c81a0d10b84cf4a041c120 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 6.77e-05 | 197 | 96 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-05 | 197 | 96 | 5 | f84f0ddf51208764ab56408d97035bbff562e59d | |
| Drug | Methylmercury Compounds | RLF SRRM1 NCOR2 SLK LMAN1 ABCB11 SMARCC2 NCAM1 SMARCE1 RAI14 CACNA1G SLC1A2 MED12 TGOLN2 CCNB1 | 2.33e-06 | 851 | 95 | 15 | ctd:D008767 |
| Drug | phenanthridinone; Up 200; 51.2uM; MCF7; HT_HG-U133A_EA | 1.66e-05 | 193 | 95 | 7 | 1115_UP | |
| Drug | Methamphetamine | RLF PRUNE2 SRRM1 NCOR2 SLK ZC3H11A MYLK AHNAK MKI67 GON4L LTBP1 SRGAP2 ZZEF1 SKA1 PCDH1 SLC1A2 SLC2A5 CCNB1 | 1.71e-05 | 1401 | 95 | 18 | ctd:D008694 |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; PC3; HG-U133A | 1.78e-05 | 195 | 95 | 7 | 1956_DN | |
| Drug | Bufexamac [2438-72-4]; Down 200; 18uM; HL60; HT_HG-U133A | 1.83e-05 | 196 | 95 | 7 | 2382_DN | |
| Drug | Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 1.83e-05 | 196 | 95 | 7 | 2296_UP | |
| Drug | Carbachol [51-83-2]; Up 200; 21.8uM; PC3; HT_HG-U133A | 1.96e-05 | 198 | 95 | 7 | 6742_UP | |
| Disease | Granuloma, Plasma Cell | 1.00e-05 | 2 | 94 | 2 | C0018199 | |
| Disease | Intellectual Disability | 9.30e-05 | 447 | 94 | 8 | C3714756 | |
| Disease | quality of life during menstruation measurement, breast pressure measurement | 1.49e-04 | 6 | 94 | 2 | EFO_0009366, EFO_0009393 | |
| Disease | Inflammatory Myofibroblastic Tumor | 1.49e-04 | 6 | 94 | 2 | C0334121 | |
| Disease | Malignant neoplasm of breast | TRERF1 ZC3H11A FXR1 G3BP2 BCORL1 MKI67 SPEN FSCB ALK MED12 AKAP12 SLC2A5 | 1.56e-04 | 1074 | 94 | 12 | C0006142 |
| Disease | schizophrenia (is_marker_for) | 3.77e-04 | 44 | 94 | 3 | DOID:5419 (is_marker_for) | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 5.42e-04 | 11 | 94 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | asthma, Eczema, allergic rhinitis | 6.17e-04 | 121 | 94 | 4 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | Huntington's disease (is_marker_for) | 6.53e-04 | 53 | 94 | 3 | DOID:12858 (is_marker_for) | |
| Disease | Coffin-Siris syndrome | 7.65e-04 | 13 | 94 | 2 | C0265338 | |
| Disease | nodular sclerosis Hodgkin lymphoma | 8.91e-04 | 14 | 94 | 2 | EFO_0004708 | |
| Disease | coronary thrombosis, GM11992 | 1.17e-03 | 16 | 94 | 2 | EFO_0001124, EFO_1000883 | |
| Disease | infant expressive language ability | 1.17e-03 | 16 | 94 | 2 | EFO_0006316 | |
| Disease | visfatin measurement | 1.32e-03 | 17 | 94 | 2 | EFO_0801230 | |
| Disease | Mental Depression | 1.34e-03 | 254 | 94 | 5 | C0011570 | |
| Disease | neutrophil count | RTF1 TRERF1 PRUNE2 ATF7 DSCAM KDM5C BCORL1 HECTD4 RCSD1 HYDIN AKAP12 TGOLN2 | 1.46e-03 | 1382 | 94 | 12 | EFO_0004833 |
| Disease | Mammary Carcinoma, Human | 1.46e-03 | 525 | 94 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.46e-03 | 525 | 94 | 7 | C1257931 | |
| Disease | dental caries, dentures | 1.47e-03 | 70 | 94 | 3 | EFO_0003819, EFO_0010078 | |
| Disease | dentures | 1.47e-03 | 70 | 94 | 3 | EFO_0010078 | |
| Disease | Mammary Neoplasms | 1.50e-03 | 527 | 94 | 7 | C1458155 | |
| Disease | pulse pressure measurement | DSCAM MAP1B TEX2 ZNF618 ABCB11 ZC3H11B NCAM1 LTBP1 UPF3A SARNP HYDIN NSD3 | 1.55e-03 | 1392 | 94 | 12 | EFO_0005763 |
| Disease | Breast Carcinoma | 1.68e-03 | 538 | 94 | 7 | C0678222 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 2.03e-03 | 21 | 94 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 | |
| Disease | in situ carcinoma (is_marker_for) | 2.03e-03 | 21 | 94 | 2 | DOID:8719 (is_marker_for) | |
| Disease | hypothyroidism (biomarker_via_orthology) | 2.15e-03 | 80 | 94 | 3 | DOID:1459 (biomarker_via_orthology) | |
| Disease | Depressive disorder | 2.35e-03 | 289 | 94 | 5 | C0011581 | |
| Disease | Ovarian Serous Adenocarcinoma | 2.43e-03 | 23 | 94 | 2 | C1335177 | |
| Disease | frailty measurement | 2.43e-03 | 23 | 94 | 2 | EFO_0009885 | |
| Disease | beta-aminoisobutyric acid measurement | 2.65e-03 | 24 | 94 | 2 | EFO_0010464 | |
| Disease | breast cancer (is_marker_for) | 2.94e-03 | 185 | 94 | 4 | DOID:1612 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KVVSPPEPEKEEAAK | 566 | Q8N163 | |
| GDKEEEPSVKLPSVP | 181 | Q9BY43 | |
| PEVKVEGPKEELEVA | 246 | P19419 | |
| AEIKVEPAEPEPVIS | 506 | Q9H0E9 | |
| PPISESQTKPKEEVE | 1426 | Q8N7X0 | |
| PFSIEEVEVAPPKAK | 21 | P28332 | |
| VEEPKPEEPKRKVDT | 661 | Q02952 | |
| ELKPKVPASPTREED | 96 | Q8NEN0 | |
| EVSEPVEPPKEDLTV | 281 | Q6IC98 | |
| PTEEEEEVTPTPAKR | 1251 | Q5H9F3 | |
| AVPKPEDDTPVQDTK | 401 | Q6JBY9 | |
| KDKDIPVQEEVEPAP | 726 | O95342 | |
| PEVDIKGPKVDIDVP | 4161 | Q09666 | |
| IKEEEPVEVDSSPPD | 106 | P17544 | |
| LKVEDEPEVLTEPPS | 1521 | O75179 | |
| EVPPTETVPQVKKEK | 286 | Q9UKL0 | |
| VEREKGTVIKPPVEE | 561 | Q9P0K7 | |
| VPLPDKIEVKTGEED | 1176 | P49792 | |
| PIKETVVEEPVDITP | 556 | Q68E01 | |
| KEEDEEPESPPEKKT | 206 | Q9H1E3 | |
| SAPPPVVPKEEKEEE | 816 | Q9Y618 | |
| VVPKEEKEEETAAAP | 821 | Q9Y618 | |
| KKVAPKEPVEETDRP | 366 | Q5TC84 | |
| LTTVGEKPEEPKDEV | 1421 | Q15746 | |
| SVTEKEVPSKEEPSP | 601 | P46821 | |
| EVPSKEEPSPVKAEV | 606 | P46821 | |
| DEPVPDSESPIEKVL | 1381 | P46821 | |
| KPEEEEPAKLPAVTV | 711 | O60721 | |
| EEAPAKVEPPTVEET | 406 | Q5H9T9 | |
| PPPDIKKEISEGDEV | 51 | P51114 | |
| TAPPEKEIPSLDQEK | 801 | Q14766 | |
| SKSPKPVKPVEDEDE | 916 | Q08174 | |
| VPEVKIDSKPPSNED | 341 | Q6ZU52 | |
| GKEPPTPDKEISEKE | 271 | P49257 | |
| KGSPSPEKPDVEKEV | 696 | Q93074 | |
| PAPEEIVEELPASKK | 3016 | P46013 | |
| EEEEGKAVVAPVEKP | 721 | Q5MIZ7 | |
| DPEKSPTKKQEVPEE | 3391 | Q9Y4D8 | |
| PEDILKEVTTPKEVP | 151 | Q9NX62 | |
| EEKPKEVSEEQPVVT | 271 | P49321 | |
| DPPSEEEDKIKEEPL | 426 | A2A2Y4 | |
| EPEPVKEEKLSPEPI | 106 | P14635 | |
| PATPEPIKLEIDEEK | 1106 | Q4G0P3 | |
| QPIKSEPESEGEEPK | 971 | Q8NHM5 | |
| SPPPETLKEKALVEV | 596 | O43497 | |
| PEPEPESETKTEELK | 196 | Q9UN86 | |
| VTKKVLVAPPPDEEA | 191 | P43004 | |
| VEEEEEPPKIPTASK | 1811 | Q3T8J9 | |
| ETVPVPPKSTAKELE | 191 | Q96DP5 | |
| EEDEIEPRPVFEKKP | 276 | Q7Z7H3 | |
| KPSPIPEVSEESEEE | 3196 | Q12955 | |
| KVEESPLEKVETPPK | 286 | Q8IWC1 | |
| PLEKVETPPKASVDA | 291 | Q8IWC1 | |
| IPEEVPKSTLESEKP | 606 | Q96T23 | |
| VETAQPAVEKPEIKP | 656 | Q9H329 | |
| LDPPKTIIPEVKEVV | 716 | Q5VV67 | |
| EKVRTEEAVPEVPPS | 691 | Q9P232 | |
| AEPIPETVKPEEKET | 211 | O75586 | |
| KAATEEPEVIPDPAK | 731 | Q15262 | |
| PDPPEIEIKDVKART | 886 | O60469 | |
| EEKEEIPPKSQPVSL | 341 | Q92541 | |
| KEDETKPEDCIPDVP | 61 | Q8TA86 | |
| KKEPEVTVVSQPTEP | 691 | Q9H2G2 | |
| KTETILPPESENPKE | 731 | Q9H2G2 | |
| SELEEEKTIPTKEPE | 2511 | Q8WUY3 | |
| EELPPKEEVAPKEEV | 516 | A4FU49 | |
| KEEVAPKEEVPPIER | 521 | A4FU49 | |
| DPEEPIKVEEPEPVK | 111 | Q96BD8 | |
| VEEPPTDPIPEDEKK | 396 | Q969G3 | |
| PESKEPVEKEEEPDP | 421 | Q9UPR3 | |
| PVKEEEPPEKTVDVA | 71 | P82979 | |
| EEPTTEKPKERGEEI | 291 | Q9H1J1 | |
| PEKEELKELPPVTSE | 486 | P22732 | |
| KLETVKEKPPEEPTT | 276 | Q9Y4P8 | |
| EKEVTPESGPPKVEE | 191 | P46087 | |
| DPIVDPEKEKEPKEG | 816 | Q8TAQ2 | |
| DDSTKPKPEEEVKPV | 381 | Q5VW32 | |
| EEEEKVPVRPKDPEG | 1406 | Q9UM73 | |
| ETETKPAPAEVKTVP | 831 | P13591 | |
| PETLVEAKEEPVEVP | 1251 | O15417 | |
| EVKSSEPTEDVEPKE | 311 | O43493 | |
| QPEEKPVEVSPAVTK | 461 | Q8N0X7 | |
| GVVATDEVKEEPPEP | 231 | Q5T7W0 | |
| DKNPPETAPVEVVEK | 2051 | Q96T58 | |
| ETAPVEVVEKKPAPE | 2056 | Q96T58 | |
| TKIKEEPPSEADPCI | 1596 | Q13129 | |
| EPVAAPEPKKETESE | 861 | Q8IYB3 | |
| VLPTVPESPEEEVKA | 101 | O75152 | |
| SPKSEIEVISEPPEE | 796 | O75044 | |
| ESDIPKSPEETIQPK | 236 | Q86VQ3 | |
| KSLEEAIPPKEIDIP | 391 | Q86VQ3 | |
| EIDIPKSPEETIQPK | 401 | Q86VQ3 | |
| EPKHEEEPKPEEKPE | 16 | Q9UHQ7 | |
| EEPKPEEKPEEEEKL | 21 | Q9UHQ7 | |
| EKIETIKPEEPLHPI | 1116 | Q9UBS9 | |
| EKPREEPVLKEEAPV | 236 | Q9BZ95 | |
| VLPTVPESPEEEVKA | 101 | A0A1B0GTU1 | |
| PKKEEPEPETEAVSS | 406 | Q15326 | |
| KPIEEKAVTPSPEQV | 2066 | O43149 | |
| IEDPEEPDPKKIKGS | 226 | Q9UNX4 | |
| GKKLPEVPPSEEEEQ | 806 | Q8IWB9 | |
| KELPPPSEEIKTGED | 531 | Q96FV9 | |
| KEVIPKEEISEESEP | 6 | Q96NJ6 | |
| TKEEESEVPKSPEPP | 976 | Q96PN7 | |
| DKEGPECPPTVVVKE | 261 | P41229 | |
| EEKGKSPVPKSPVEE | 636 | P07197 |